An immunotherapy approach to treating advanced Hodgkin lymphoma may drastically increase patients’ chances of survival, ...

A groundbreaking study led by researchers at the Wilmot Cancer Institute has shown that an immunotherapy treatment ...

It may soon be possible to determine which patients with a type of liver cancer called hepatocellular carcinoma would benefit from immunotherapy, according to a preclinical study.

So now a new multimillion-pound research programme aims to discover why at least half of all patients fail to respond to ...

Columbia researchers have created personalized probiotic bacteria that train the immune system to eliminate cancer cells. In ...

A treatment that rallies the immune system to destroy cancer raised the survival rate for advanced Hodgkin lymphoma patients ...

According to a preclinical study conducted by Weill Cornell Medicine researchers, it may soon be feasible to detect whether individuals with hepatocellular carcinoma, a kind of liver cancer, may ...

Black men with advanced prostate cancer have a greater chance of survival after immunotherapy treatment, at least in part, because of ancestral gene variants in immune responses.

The bacterial vaccine proved to be particularly more efficacious than peptide-based therapeutic cancer vaccines ...

Immunotherapy has set a new standard in treating Hodgkin lymphoma, showing a 92% survival rate and fewer long-term side effects, with FDA approval anticipated soon. A new treatment that activates the ...

Discover key gene signatures that could help predict the efficacy of immune checkpoint blockade therapy in patients with ...

Adding immunotherapy to platinum chemotherapy can improve outcomes of urothelial carcinoma, but that may depend on the platinum agent used.